litlas
Log inCreate account

Sanjay Popat

Active 1999–2026

155
Papers
26,009
Citations
58
h-index
139
i10-index

Citations

Citations per year for Sanjay Popat1993: 1 citations2001: 1 citations2002: 4 citations2003: 5 citations2004: 1 citations2005: 19 citations2006: 21 citations2007: 19 citations2008: 37 citations2009: 47 citations2010: 67 citations2011: 66 citations2012: 48 citations2013: 68 citations2014: 74 citations2015: 100 citations2016: 147 citations2017: 144 citations2018: 175 citations2019: 849 citations2020: 1,132 citations2021: 1,341 citations2022: 1,036 citations2023: 850 citations2024: 1,572 citations2025: 839 citations2026: 18 citations1994–2000: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,231 citing papers, 17.2% of this breakdownChina: 1,509 citing papers, 11.7% of this breakdownItaly: 1,006 citing papers, 7.8% of this breakdownUnited Kingdom: 886 citing papers, 6.9% of this breakdownFrance: 702 citing papers, 5.4% of this breakdownGermany: 604 citing papers, 4.7% of this breakdownSpain: 598 citing papers, 4.6% of this breakdownJapan: 560 citing papers, 4.3% of this breakdownNetherlands: 455 citing papers, 3.5% of this breakdownSwitzerland: 374 citing papers, 2.9% of this breakdownCanada: 364 citing papers, 2.8% of this breakdownSouth Korea: 355 citing papers, 2.7% of this breakdown
0%17.2%Other 25.5%

Institutions

Fields

  • Medicine78.1%
  • Biochemistry, Genetics and Molecular Biology17.1%
  • Immunology and Microbiology1.8%
  • Computer Science0.6%
  • Engineering0.5%
  • Agricultural and Biological Sciences0.4%
  • Other1.5%

Topics

  • Lung Cancer Treatments and Mutations14.5%
  • Cancer Immunotherapy and Biomarkers8.3%
  • Lung Cancer Research Studies7.7%
  • Lung Cancer Diagnosis and Treatment6.1%
  • Cancer Genomics and Diagnostics5.2%
  • Colorectal Cancer Treatments and Studies3.3%
  • Other54.9%

Coauthors

All papers

Open in search
  1. ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group

    Authors: Javier Pascual, Gerhardt Attard, François‐Clément Bidard, Giuseppe Curigliano, Leticia De Mattos‐Arruda, Maximilian Diehn, Antoîne Italiano, Johan Lindberg, Jason D. Merker, Clara Montagut, Nicola Normanno, Klaus Pantel, George Pentheroudakis, Sanjay Popat, Jorge S. Reis‐Filho, Jeanne Tie, Joan Seoane, N. Tarazona, Takayuki Yoshino, Nicholas C. Turner - Annals of Oncology 2022 cited by 664

  2. Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry

    Authors: J. Mazieres, Alexander Drilon, Amélie Lusque, Laurent Mhanna, Alexis B. Cortot, Laura Mezquita, Alesha A. Thai, Céline Mascaux, S. Couraud, Rémi Veillon, Michel M. van den Heuvel, Joel W. Neal, Nir Peled, Martin Früh, Terry L. Ng, V. Gounant, Sanjay Popat, Joachim Diebold, Joshua K. Sabari, Viola W. Zhu, Sacha I. Rothschild, Paolo Bironzo, Alex Martínez‐Martí, Alessandra Curioni‐Fontecedro, Rafael Rosell, Mickaël Lattuca-Truc, Marcel Wiesweg, Benjamin Besse, Benjamin Solomon, Fabrice Barlési, Robert D. Schouten, Heather A. Wakelee, D. Ross Camidge, Gérard Zalcman, Silvia Novello, Sai‐Hong Ignatius Ou, Julie Milia, Oliver Gautschi - Annals of Oncology 2019 cited by 1,361

  3. First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial

    Authors: Paul Baas, Arnaud Scherpereel, Anna K. Nowak, Nobukazu Fujimoto, Solange Peters, Anne S. Tsao, Aaron S. Mansfield, Sanjay Popat, Thierry Jahan, Scott Antonia, Youssef Oulkhouir, Yolanda Bautista, Robin Cornelissen, Laurent Greillier, Francesco Grossi, Dariusz M. Kowalski, Jerónimo Rafael Rodríguez‐Cid, Praveen Aanur, Abderrahim Oukessou, Christine Baudelet, Gérard Zalcman - The Lancet 2021 cited by 1,194

  4. Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Authors: David Planchard, Sanjay Popat, Keith M. Kerr, Silvia Novello, Egbert F. Smit, Corinne Faivre‐Finn, Tony Mok, Martin Reck, Paul E. Van Schil, Matthew D. Hellmann, Solange Peters - Annals of Oncology 2018 cited by 2,299

  5. Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study

    Authors: Antonio Passaro, Jing Wang, Yan Wang, S.-H. Lee, Barbara Melosky, Jin‐Yuan Shih, Jing Wang, K. Azuma, Óscar Juan, Manuel Cobo, Enriqueta Felip, Nicolas Girard, Alexis B. Cortot, Raffaele Califano, Federico Cappuzzo, Scott Owen, Sanjay Popat, Ju Le Tan, Jorge Salinas, Pascale Tomasini, Ryan D. Gentzler, William N. William, Karen L. Reckamp, Toshiaki Takahashi, Sandip Ganguly, Dariusz M. Kowalski, Alessandra Bearz, Melanie Mackean, P. Barala, Ariel B. Bourla, Angela Girvin, James Greger, Dawn Millington, Monica Withelder, John Xie, Tao Sun, Shalin Shah, B. Diorio, Roland E. Knoblauch, Joshua Bauml, Rosario García Campelo, Byoung Chul Cho - Annals of Oncology 2023 cited by 396

  6. Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions

    Authors: Caicun Zhou, Kejing Tang, Byoung Chul Cho, Baogang Liu, Luis Paz‐Ares, Susanna Y. Cheng, Satoru Kitazono, Muthukkumaran Thiagarajan, Jonathan W. Goldman, Joshua K. Sabari, Rachel E. Sanborn, Aaron S. Mansfield, Jen‐Yu Hung, Michael Boyer, Sanjay Popat, Josiane Mourão Dias, Enriqueta Felip, Margarita Majem, Mahmut Gümüş, Sang‐We Kim, Akira Ono, John Xie, Archan Bhattacharya, Trishala Agrawal, S. Martin Shreeve, Roland E. Knoblauch, Keunchil Park, Nicolas Girard - New England Journal of Medicine 2023 cited by 347

  7. RETRACTED ARTICLE: Antibodies against endogenous retroviruses promote lung cancer immunotherapy

    Authors: Kevin W. Ng, Jesse Boumelha, Katey S.S. Enfield, Jorge Almagro, Hongui Cha, Oriol Pich, Takahiro Karasaki, David A. Moore, Roberto Salgado, Monica Sivakumar, George R. Young, Míriam Molina‐Arcas, Sophie de Carné Trécesson, Panayiotis Anastasiou, Annika Fendler, Lewis Au, Scott T.C. Shepherd, Carlos Martínez‐Ruiz, Clare Puttick, James R. Black, Thomas B.K. Watkins, Hye Min Kim, Seohee Shim, Nikhil Faulkner, Jan Attig, Selvaraju Veeriah, Neil Magno, Sophia Ward, Alexander M. Frankell, Maise Al Bakir, Emilia L. Lim, Mark S. Hill, Gareth A. Wilson, Daniel E. Cook, Nicolai J. Birkbak, Axel Behrens, Nadia Yousaf, Sanjay Popat, Allan Hackshaw, Andrew Rowan, Ariana Huebner, Brittany Campbell, Chris Bailey, Claudia Lee, Dhruva Biswas, Emma Colliver, Foteini Athanasopoulou, Hao-Ran Zhai, Jayant K. Rane, Kristiana Grigoriadis, Michelle Dietzen, Michelle Leung, Mihaela Angelova, Olivia Lucas, Othman Al‐Sawaf, Rachel Rosenthal, Jérôme Nicod, Abigail Bunkum, Antonia Toncheva, Christopher Abbosh, Corentin Richard, Cristina Naceur‐Lombardelli, Francisco Gimeno-Valiente, Jie Min Lam, Kerstin Thol, Krupa Thakkar, Mariana Werner Sunderland, Martin Förster, Nnennaya Kanu, Paulina Prymas, Robert B. Bentham, Sadegh Saghafinia, Sergio A. Quezada, Sharon Vanloo, Simone Zaccaria, Siow Ming Lee, Sonya Hessey, Wing Kin Liu, Dionysis Papadatos-Pastos, James M. Wilson, Sarah Benafif, Tanya Ahmad, Elaine Borg, Mary Falzon, Reena Khiroya, Teresa Marafioti, Abigail Sharp, Camilla Pilotti, Harjot Kaur Dhanda, Kitty S. Chan, Nicole Gower, Rachel Leslie, Sean Smith, Andrew G. Nicholson, Eric Lim, Javier Herrero, Carla Castignani, Elizabeth Larose Cadieux, Jonas Demeulemeester, Peter Van Loo and 231 more - Nature 2023 cited by 249

  8. Brigatinib versus Crizotinib in ALK -Positive Non–Small-Cell Lung Cancer

    Authors: D. Ross Camidge, Hye Ryun Kim, Myung‐Ju Ahn, James Chih‐Hsin Yang, Ji‐Youn Han, Jong Seok Lee, Maximilian J. Hochmair, Jacky Yu-Chung Li, Gee‐Chen Chang, Ki Hyeong Lee, Cesare Gridelli, Angelo Delmonte, Rosario García Campelo, Dong‐Wan Kim, Alessandra Bearz, Frank Griesinger, Alessandro Morabito, Enriqueta Felip, Raffaele Califano, Sharmistha Ghosh, Alexander I. Spira, Scott Gettinger, Marcello Tiseo, Neeraj Gupta, J. Haney, David Kerstein, Sanjay Popat - New England Journal of Medicine 2018 cited by 976

  9. Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Authors: Silvia Novello, Fabrice Barlési, Raffaele Califano, Tanja Čufer, Simon Ekman, Matteo Giaj Levra, Keith M. Kerr, Sanjay Popat, Martin Reck, Suresh Senan, G.V. Simo, Johan Vansteenkiste, Solange Peters - Annals of Oncology 2016 cited by 2,636

  10. Brigatinib Versus Crizotinib in ALK Inhibitor–Naive Advanced ALK-Positive NSCLC: Final Results of Phase 3 ALTA-1L Trial

    Authors: D. Ross Camidge, Hye Ryun Kim, Myung‐Ju Ahn, James Chih‐Hsin Yang, Ji‐Youn Han, Maximilian J. Hochmair, Ki Hyeong Lee, Angelo Delmonte, M.R. García Campelo, Dong‐Wan Kim, Frank Griesinger, Enriqueta Felip, Raffaele Califano, Alexander I. Spira, Scott Gettinger, Marcello Tiseo, Huamao Mark Lin, Yuyin Liu, Florin Vranceanu, Huifeng Niu, Pingkuan Zhang, Sanjay Popat - Journal of Thoracic Oncology 2021 cited by 372

  11. First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743

    Authors: Solange Peters, Arnaud Scherpereel, Robin Cornelissen, Youssef Oulkhouir, Laurent Greillier, Kaplan Ma, Thomas Talbot, I. Monnet, Sandrine Hiret, P. Baas, Anna K. Nowak, Nobukazu Fujimoto, Anne S. Tsao, Aaron S. Mansfield, Sanjay Popat, X. Zhang, Nan Hu, David Balli, Thomas Spires, Gérard Zalcman - Annals of Oncology 2022 cited by 263

  12. Repotrectinib in ROS1 Fusion–Positive Non–Small-Cell Lung Cancer

    Authors: Alexander Drilon, D. Ross Camidge, W. Marston Linehan, Sang‐We Kim, Benjamin Solomon, Rafał Dziadziuszko, Benjamin Besse, Kōichi Goto, Adrianus J. de Langen, Jürgen Wolf, Ki Hyeong Lee, Sanjay Popat, Christoph Springfeld, Misako Nagasaka, Enriqueta Felip, Nong Yang, Vamsidhar Velcheti, Shun Lü, Steven Kao, Christophe Dooms, Matthew Krebs, Wenxiu Yao, Muhammad Shaalan Beg, Xiufeng Hu, Denis Moro‐Sibilot, Parneet Cheema, Shanna Stopatschinskaja, Minal Mehta, Denise Trone, Armin Graber, Gregory E. Sims, Yong Yuan, Byoung Chul Cho - New England Journal of Medicine 2024 cited by 210

  13. Systematic Review of Microsatellite Instability and Colorectal Cancer Prognosis

    Authors: Sanjay Popat, Richard Hubner, Richard S. Houlston - Journal of Clinical Oncology 2005 cited by 1,828

  14. Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC–ESTRO OligoCare consortium

    Authors: Stephanie Kroeze, Matea Pavic, Karin Stellamans, Yolande Lievens, Carlotta Becherini, Marta Scorsetti, Filippo Alongi, Umberto Ricardi, Barbara Alicja Jereczek‐Fossa, Paulien G. Westhoff, Jasna But-Hadžić, Joachim Widder, Xavier Geets, Samuel Bral, Maarten Lambrecht, Charlotte Billiet, Igor Sirák, Sara Ramella, Ivaldi Giovanni Battista, Sergi Benavente, A. Zapatero, Fabiola Romero, Thomas Zilli, K. Khanfir, Hossein Hemmatazad, Berardino De Bari, Desiree N Klass, Shaukat Adnan, Heike Peulen, J. Salinas Ramos, Michiel Strijbos, Sanjay Popat, Piet Ost, Matthias Gückenberger - The Lancet Oncology 2023 cited by 172

  15. Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials

    Authors: James Chih‐Hsin Yang, Yi‐Long Wu, Martin Schüler, Martin Sebastian, Sanjay Popat, Nobuyuki Yamamoto, Caicun Zhou, Cheng-Ping Hu, Kenneth J. O’Byrne, Jifeng Feng, Shun Lü, Yunchao Huang, Sarayut Lucien Geater, Kye Young Lee, Chun-Ming Tsai, В. А. Горбунова, Vera Hirsh, Jaafar Bennouna, С. В. Орлов, Tony Mok, Michael Boyer, Wu‐Chou Su, Ki Hyeong Lee, Terufumi Kato, Dan Massey, Mehdi Shahidi, Victoria Zazulina, Lecia V. Sequist - The Lancet Oncology 2015 cited by 1,580

  16. Brigatinib Versus Crizotinib in Advanced ALK Inhibitor–Naive ALK-Positive Non–Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial

    Authors: D. Ross Camidge, Hye Ryun Kim, Myung‐Ju Ahn, James Chih‐Hsin Yang, Ji‐Youn Han, Maximilian J. Hochmair, Ki Hyeong Lee, Angelo Delmonte, M.R. García Campelo, Dong‐Wan Kim, Frank Griesinger, Enriqueta Felip, Raffaele Califano, Alexander I. Spira, Scott Gettinger, Marcello Tiseo, Huamao Mark Lin, Neeraj Gupta, Michael J. Hanley, Quanhong Ni, Pingkuan Zhang, Sanjay Popat - Journal of Clinical Oncology 2020 cited by 367

  17. EZH2 inhibitor tazemetostat in patients with relapsed or refractory, BAP1-inactivated malignant pleural mesothelioma: a multicentre, open-label, phase 2 study

    Authors: Marjorie G. Zauderer, Peter W. Szlosarek, Sylvestre Le Moulec, Sanjay Popat, Paul Taylor, David Planchard, Arnaud Scherpereel, Marianna Koczywas, Martin Förster, Robert B. Cameron, Tobias Peikert, Evren Kocabaş Argon, Neil R. Michaud, Attila Szántó, Jay Yang, Yingxue Chen, Vikram Kansra, Shefali Agarwal, Dean A. Fennell - The Lancet Oncology 2022 cited by 131

  18. SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer

    Authors: Hossein Borghaei, Filippo de Marinis, Daphne W. Dumoulin, Craig H. Reynolds, Willemijn S.M.E. Theelen, Ivor Percent, V. Gutiérrez Calderón, Melissa L. Johnson, Anne Madroszyk, Edward B. Garon, Kai He, David Planchard, Martin Reck, Sanjay Popat, Roy S. Herbst, Ticiana Leal, Ronald Shazer, Xin Yan, Richard Harrigan, Solange Peters, Isam Abdel-Karim, Mahmoud Abdelsalam, Alfredo Addeo, Carlos Aguado, Patrick Alexander, Jürgen Alt, Georges Azzi, Rama Balaraman, Bonne Biesma, Fiona Blackhall, Sabine Bohnet, Ekaterini Boleti, Hossein Borghaei, Penelope A. Bradbury, Matteo Brighenti, Nicholas Campbell, Toby Campbell, Jean-Luc Canon, Federico Cappuzzo, Enric Carcereny Costa, Luigi Cavanna, Jeremy Cetnar, Antonio Chella, C. Chouaïd, Daniel C. Christoph, J. Cortés Castán, Shaker R. Dakhil, F.J. de Castro Carpeño, Filippo de Marinis, Angelo Delmonte, Ingel Demedts, Wim Demey, Joyce Dits, Maria del Pilar Diz Taín, M. Dómine Gómez, Timothy Dorius, Daphne W. Dumoulin, M. Duruisseaux, Keith D. Eaton, Emilio Esteban González, Devon Evans, Martin Faehling, Nicholas Farrell, Trevor Feinstein, E. Felip Font, M.R. García Campelo, Edward B. Garon, María Pilar Garrido López, Paul Germonpré, Todd Gersten, María González Cao, Srivalli Gopaluni, Laurent Greillier, Francesco Grossi, Florian Guisier, Sarada Gurubhagavatula, Vanesa Gutiérrez Calderón, David Hakimian, Richard D. Hall, Desirée Hao, Ronald Harris, Sayed M.S. Hashemi, Kai He, Lizza Hendriks, Chao Huang, Emad Ibrahim, Sharad Jain, Melissa L. Johnson, B. J. P. Jones, Monte Jones, Óscar Juan, Rosalyn A. Juergens, Courèche Kaderbhaï, Elisabeth A. Kastelijn, Roger Keresztes, Ebenezer A. Kio, Konrad Kokowski, Kartik Konduri, Swati Kulkarni, Jonas Kuon and 84 more - Annals of Oncology 2023 cited by 93

  19. ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer

    Authors: Antonio Passaro, Natasha B. Leighl, Fiona Blackhall, Sanjay Popat, Keith M. Kerr, Myung‐Ju Ahn, Maria E. Arcila, Óscar Arrieta, David Planchard, Filippo de Marinis, Anne‐Marie C. Dingemans, Rafał Dziadziuszko, Corinne Faivre‐Finn, Jill Feldman, Enriqueta Felip, Giuseppe Curigliano, Roy S. Herbst, Pasi A. Jänne, Thomas John, Tetsuya Mitsudomi, Tony Mok, Nicola Normanno, Luis Paz‐Ares, Suresh S. Ramalingam, Lecia V. Sequist, Johan Vansteenkiste, Ignacio I. Wistuba, Juergen Wolf, Yi‐Long Wu, Sihai Yang⧫, James Chih‐Hsin Yang, Yasushi Yatabe, George Pentheroudakis, Solange Peters - Annals of Oncology 2022 cited by 190

  20. Recent Advances on the Role of EGFR Tyrosine Kinase Inhibitors in the Management of NSCLC With Uncommon, Non Exon 20 Insertions, EGFR Mutations

    Authors: Antonio Passaro, Tony Mok, Solange Peters, Sanjay Popat, Myung‐Ju Ahn, Filippo de Marinis - Journal of Thoracic Oncology 2020 cited by 213

  21. 1372P Repotrectinib in patients (pts) with NTRK fusion-positive (NTRK+) advanced solid tumors, including NSCLC: Update from the phase I/II TRIDENT-1 trial

    Authors: Benjamin Solomon, Alexander Drilon, W. Marston Linehan, Lyudmila Bazhenova, Keiko Goto, J. De Langen, Dongwook Kim, Jennifer Moriatis Wolf, Christoph Springfeld, Sanjay Popat, Wan‐Teck Lim, Christina S. Baik, Alice Hervieu, V. Moreno Garcia, Nong Yang, S. Thamake, Felipe Ades, D. Trone, Benjamin Besse - Annals of Oncology 2023 cited by 56

  22. A multicentre randomised phase III trial comparing pembrolizumab versus single-agent chemotherapy for advanced pre-treated malignant pleural mesothelioma: the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial

    Authors: Sanjay Popat, Alessandra Curioni‐Fontecedro, Urania Dafni, R. Shah, Mary O’Brien, A. Pope, P.M. Fisher, James Spicer, A. Roy, David Gilligan, Oliver Gautschi, Ernest Nadal, Wolf-Dieter Janthur, Rafael López Castro, Rosario García Campelo, Sylvie Rusakiewicz, Igor Letovanec, Varvara Polydoropoulou, Heidi Roschitzki‐Voser, Barbara Ruepp, A. Gasca-Ruchti, Solange Peters, Rolf A. Stahel - Annals of Oncology 2020 cited by 273

  23. Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy – results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial

    Authors: Solange Peters, Jean-Louis Pujol, Urania Dafni, Manuel Dómine, Sanjay Popat, Martin Reck, J. Andrade, A. Becker, Denis Moro‐Sibilot, Alessandra Curioni‐Fontecedro, Olivier Molinier, Kristiaan Nackaerts, A. Insa Mollá, R. Gervais, Guillermo López-Vivanco, J. Madelaine, Julien Mazières, Martin Faehling, Frank Griesinger, Margarita Majem, J.L. González-Larriba, M. Provencio Pulla, Katerina Vervita, Heidi Roschitzki‐Voser, Barbara Ruepp, Paul Mitchell, Rolf A. Stahel, C. Le Péchoux, Dirk De Ruysscher, Rolf A. Stahel, Anita Hiltbrunner, Mariana Pardo-Contreras, A. Gasca-Ruchti, Nino Giacomelli, Roswitha Kammler, Nesa Marti, Rita Pfister, Anne‐Christine Piguet, Susanne Roux, Sandra Troesch, M. Schneider, Robin Schweri, Isabel Zigomo, Zoi Tsourti, Panagiota Zygoura, S. Tsouprou, Marie Kassapian, Katerina Vervita, Georgia Dimopoulou, Charitini Andriakopoulou, Franck Morin, Elodie Amour, G. Mariaule, N. Archirel, María Dolores Arnaiz Fernández, E. Pereira, M. Fernandez, K. Lopez, Ainhoa Hernández, Sarah Chinchen, H. Jurkovic, Alan S. Livingstone, Jerry W. Mitchell, Macie B. Walker, Paul Mitchell, S. Ng, Christopher Steer, Karen Briscoe, Amina Saqib, Ehtesham Abdi, Baerin Houghton, Kenneth J. O’Byrne, B.R. Chittajallu, Brett Hughes, A. Black, Kristiaan Nackaerts, Henrica M.J. Werner, R. Gervais, Gérard Zalcman, F. Vaylet, P. Merle, I. Monnet, Denis Moro‐Sibilot, Olivier Molinier, Nicolas Girard, P.-J. Souquet, Fabrice Barlési, D. Debieuvre, Hélène Senellart, M. Poudenx, A. Dixmier, Damien Pouessel, Jacques Cadranel, H. Léna, Élisabeth Quoix, S. Friard, Clarisse Audigier-Valette, Julien Mazières, Éric Pichon, Martin Faehling and 20 more - Annals of Oncology 2021 cited by 114

  24. Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆

    Authors: Sanjay Popat, P. Baas, Corinne Faivre‐Finn, Nicolas Girard, Andrew G. Nicholson, Anna K. Nowak, Isabelle Opitz, Arnaud Scherpereel, Martin Reck - Annals of Oncology 2021 cited by 227